Skip to content
10-K

Annual Report

KERYX BIOPHARMACEUTICALS INC

0001114220-18-000029

← back to feed
Filed
Feb 21, 2018 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Feb 9, 2018 119.18M sh
Capex FY 2017 · Dec 31, 2017 $1.26M
Capex FY 2017 · Dec 31, 2016 $2.07M
Capex FY 2017 · Dec 31, 2015 $2.78M
Cash And Equivalents FY 2017 · Dec 31, 2017 $93.53M
Cash And Equivalents FY 2017 · Dec 31, 2016 $111.81M
Cash And Equivalents FY 2017 · Dec 31, 2015 $200.29M
Cash And Equivalents FY 2017 · Dec 31, 2014 $74.28M
Stockholders Equity FY 2017 · Dec 31, 2017 −$14.1M
Stockholders Equity FY 2017 · Dec 31, 2016 −$8.3M
Stockholders Equity FY 2017 · Dec 31, 2015 $86.93M
Stockholders Equity FY 2017 · Dec 31, 2014 $73.48M
Current Liabilities FY 2017 · Dec 31, 2017 $45.42M
Current Liabilities FY 2017 · Dec 31, 2016 $21.55M
Total Liabilities FY 2017 · Dec 31, 2017 $172.97M
Total Liabilities FY 2017 · Dec 31, 2016 $149.72M
Current Assets FY 2017 · Dec 31, 2017 $141.57M
Current Assets FY 2017 · Dec 31, 2016 $132.9M
Total Assets FY 2017 · Dec 31, 2017 $158.87M
Total Assets FY 2017 · Dec 31, 2016 $141.43M
Sga Expense FY 2017 · Dec 31, 2017 $28.79M
Sga Expense FY 2017 · Dec 31, 2017 $99.62M
Sga Expense FY 2017 · Sep 30, 2017 $22.75M
Sga Expense FY 2017 · Jun 30, 2017 $24.99M
Sga Expense FY 2017 · Mar 31, 2017 $23.1M
Sga Expense FY 2017 · Dec 31, 2016 $23.04M
Sga Expense FY 2017 · Dec 31, 2016 $84.55M
Sga Expense FY 2017 · Sep 30, 2016 $20.52M
Sga Expense FY 2017 · Jun 30, 2016 $20.19M
Sga Expense FY 2017 · Mar 31, 2016 $20.81M
Sga Expense FY 2017 · Dec 31, 2015 $81.41M
Rd Expense FY 2017 · Dec 31, 2017 $12.63M
Rd Expense FY 2017 · Dec 31, 2017 $37.68M
Rd Expense FY 2017 · Sep 30, 2017 $9.28M
Rd Expense FY 2017 · Jun 30, 2017 $9.01M
Rd Expense FY 2017 · Mar 31, 2017 $6.76M
Rd Expense FY 2017 · Dec 31, 2016 $6.19M
Rd Expense FY 2017 · Dec 31, 2016 $29.5M
Rd Expense FY 2017 · Sep 30, 2016 $8.67M
Rd Expense FY 2017 · Jun 30, 2016 $7.03M
Rd Expense FY 2017 · Mar 31, 2016 $7.62M
Rd Expense FY 2017 · Dec 31, 2015 $36.69M
Net Income FY 2017 · Dec 31, 2017 −$30.43M
Net Income FY 2017 · Dec 31, 2017 −$163.44M
Net Income FY 2017 · Sep 30, 2017 −$23.5M
Net Income FY 2017 · Jun 30, 2017 −$86.5M
Net Income FY 2017 · Mar 31, 2017 −$23.02M
Net Income FY 2017 · Dec 31, 2016 −$33.78M
Net Income FY 2017 · Dec 31, 2016 −$161.1M
Net Income FY 2017 · Sep 30, 2016 −$41.7M
Net Income FY 2017 · Jun 30, 2016 −$44.65M
Net Income FY 2017 · Mar 31, 2016 −$40.96M
Net Income FY 2017 · Dec 31, 2015 −$123.15M
Operating Income FY 2017 · Dec 31, 2017 −$31.01M
Operating Income FY 2017 · Dec 31, 2017 −$101.69M
Operating Income FY 2017 · Sep 30, 2017 −$23.72M
Operating Income FY 2017 · Jun 30, 2017 −$23.85M
Operating Income FY 2017 · Mar 31, 2017 −$23.11M
Operating Income FY 2017 · Dec 31, 2016 −$33.91M
Operating Income FY 2017 · Dec 31, 2016 −$122.76M
Operating Income FY 2017 · Sep 30, 2016 −$41.83M
Operating Income FY 2017 · Jun 30, 2016 −$23.63M
Operating Income FY 2017 · Mar 31, 2016 −$23.4M
Operating Income FY 2017 · Dec 31, 2015 −$111.07M
Cost Of Revenue FY 2017 · Dec 31, 2017 $7.45M
Cost Of Revenue FY 2017 · Dec 31, 2017 $21.96M
Cost Of Revenue FY 2017 · Sep 30, 2017 $5.86M
Cost Of Revenue FY 2017 · Jun 30, 2017 $4.38M
Cost Of Revenue FY 2017 · Mar 31, 2017 $4.27M
Cost Of Revenue FY 2017 · Dec 31, 2016 $13.44M
Cost Of Revenue FY 2017 · Dec 31, 2016 $37.8M
Cost Of Revenue FY 2017 · Sep 30, 2016 $18.2M
Cost Of Revenue FY 2017 · Jun 30, 2016 $5.1M
Cost Of Revenue FY 2017 · Mar 31, 2016 $1.07M
Cost Of Revenue FY 2017 · Dec 31, 2015 $4.52M